No Data
Case Against Chempartner Pharmatech Chair Dropped
Chempartner Pharmatech to Issue Up to 931 Million Yuan of Shares
ChemPartner PharmaTech (300149.SZ): The actual controller will change to WOO SWEE LIAN.
On December 13, 2023, Glonghui reported that ChemPartner PharmaTech (300149.SZ) announced, according to the Civil Mediation Document No. (2024) Yue 07 Min Chu 66 issued by the Intermediate People's Court of Jiangmen City, Guangdong Province, that the company's shareholder Beihai Baben Venture Capital Co., Ltd. agrees to transfer 30,033,098 shares of ChemPartner PharmaTech held by Beihai Baben Venture Capital Co., Ltd. to Mr. WOO SWEE LIAN within fifteen days starting from the effective date of the mediation document (November 27, 2024), and to complete the transfer registration procedures, with the transfer price based on the day before the mediation document takes effect.
ChemPartner PharmaTech (300149.SZ): The Chairman received the "Decision to Revoke the Case".
Gelonghui, December 13: ChemPartner PharmaTech (300149.SZ) announced that the company's Chairman Mr. WOO SWEE LIAN was recently notified that he received the decision letter No. 168 on the dismissal of the case issued by the Jilin Municipal Public Security Bureau.
ChemPartner PharmaTech (300149.SZ): Plans to raise no more than 0.931 billion yuan through a private placement.
On December 13, Gelonghui reported that ChemPartner PharmaTech (300149.SZ) announced the plan for the issuance of Stocks to specific entities for 2024. The recipients of the Stocks issued to specific entities will be Rui Lian Investment (to be established), which has signed a "Conditionally Effective Share Subscription Agreement" with the company and intends to subscribe for the issued Stocks in Cash. The total funds raised from this issuance of Stocks to specific entities are expected to not exceed 930.6947 million yuan (including this amount), and the net amount raised after deducting issuance expenses will be used entirely to supplement working capital and repay bank loans.
Is ChemPartner PharmaTechLtd (SZSE:300149) Using Debt Sensibly?
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 31% But Its Business Prospects Need A Lift Too
